Related references
Note: Only part of the references are listed.Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease
T. Botta-Orfila et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Replication of MAPT and SNCA, but not PARK16-18, as Susceptibility Genes for Parkinson's Disease
Ignacio F. Mata et al.
MOVEMENT DISORDERS (2011)
SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein Level
Ignacio F. Mata et al.
ARCHIVES OF NEUROLOGY (2010)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Genetic variability in the SNCA gene influences α-synuclein levels in the blood and brain
Julia Fuchs et al.
FASEB JOURNAL (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
Demetrius M. Maraganore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
SNPStats:: a web tool for the analysis of association studies
Xavier Sole et al.
BIOINFORMATICS (2006)
LRRK2 mutations in Spanish patients with Parkinson disease -: Frequency, clinical features, and incomplete penetrance
C Gaig et al.
ARCHIVES OF NEUROLOGY (2006)
Multiple regions of α-synuclein are associated with Parkinson's disease
JC Mueller et al.
ANNALS OF NEUROLOGY (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)